Interleukin-1 beta in Major Depressive Disorder

Interleukin-1 beta belongs to the other group of Major Depressive Disorder markers and is reported to be raised relative to healthy controls. The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. This entry summarises Lorkiewicz et al. 2021. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedOther

Summary

Direction in Major Depressive Disorder↑ Elevated — higher than in the comparison group
CategoryOther
Compared againsthealthy controls
SourceLorkiewicz et al. 2021 — doi:10.3390/jcm10184142
Condition atlasMajor Depressive Disorder Biomarker Atlas

Other conditions where Interleukin-1 beta is reported

See the cross-condition hub: Interleukin-1 beta across conditions.

Related Other markers in Major Depressive Disorder

Full list: Major Depressive Disorder Biomarker Atlas.

Frequently asked questions

Is Interleukin-1 beta high or low in Major Depressive Disorder?

Elevated. Studies summarised in the OSMF atlas report higher Interleukin-1 beta in Major Depressive Disorder than in healthy controls. Source: Lorkiewicz et al. 2021.

Which test measures Interleukin-1 beta?

The atlas record does not list a standardised clinical test code (LOINC) for Interleukin-1 beta, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Interleukin-1 beta result diagnostic of Major Depressive Disorder?

No. No single biomarker is diagnostic of Major Depressive Disorder. Interleukin-1 beta findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Interleukin-1 beta specific to Major Depressive Disorder?

No. The same marker is also reported in Low Back Pain in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Interleukin-1 beta in Major Depressive Disorder: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/major-depressive-disorder/interleukin-1-beta.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from major-depressive-disorder.json · Browse: Major Depressive Disorder atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.